Our findings uncovered significant positive correlations between ZNF280A expression and clinical grade (p < 0.001), tumor size (p < 0.001), and tumor-node-metastasis staging (p < 0.05) (Tables 2 and 3), implying that ZNF280A upregulation parallels disease progression. The gene discussed is ZNF280A; the disease is neoplasm.